Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies

NCT06508775 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma Stage III
B-cell Non Hodgkin Lymphoma
Pediatric ALL
Childhood Non-Hodgkin Lymphoma
Acute Lymphatic Leukemia
Chronic Lymphatic Leukemia
Melanoma Stage IV

Interventions

BIOLOGICAL: MB-CART19.1
BIOLOGICAL: MB-CART20.1
BIOLOGICAL: MB-CART2019.1

Sponsor

Miltenyi Biomedicine GmbH